Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Three-year comparison of natalizumab versus mitoxantrone induction followed by long-term immunomodulator in aggressive relapsing multiple sclerosis
2009-015587-34Phase 4Completed
- Sponsor
- CHU Rennes
- Start
- Sep 2009
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of natalizumab and mitoxantrone in multiple sclerosis (MS) (2 arms), sponsored by CHU Rennes. Started Sep 2009; status: completed.
02
Drugs
natalizumabmitoxantrone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-015587-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015587-34.